Anxiolytic-like effects of 4-phenyl-2-trichloromethyl-3h-1,5-benzodiazepine hydrogen sulfate in mice

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 9, 2000, Pages 1069-1073

  Rubin, M A ^a,b   Albach, C A ^a   Berlese, D B ^a   Bonacorso, H G ^a   Bittencourt, S R T ^a   Queiroz, C M T ^a   Maixner, A E ^a   Mello, C F ^a  

^a Departament of Matematica   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

1,5 Benzodiazepine; Anxiolytic; Diazepam; Elevated plus maze; Holeboard; Picrotoxin

Indexed keywords

4 PHENYL 2 TRICHLOROMETHYL 3H 1,5 BENZODIAZEPINE HYDROGEN SULFATE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; PICROTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MAZE TEST; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; SYNTHESIS; TRANQUILIZING ACTIVITY;

ANIMALIA;

EID: 0033774744     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000900013     Document Type: Article

References (17)

1. Wolfman C, Viola H, Paladini A, Dajas F & Medina JH (1994). Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulae. Pharmacology, Biochemistry and Behavior, 47: 1-4.
2. Yasumatsu H, Morimoto Y, Yamamoto Y, Takehara S, Fukuda T, Nakao T & Setoguchi M (1994). The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist. British Journal of Pharmacology, 111: 1170-1178.
3. van Gerven JM, Roncari G, Schoemaker RC, Massarella J, Keesmaat P, Kooyman H, Heizmann P, Zell M, Cohen AF & Dingemanse J (1997). Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. British Journal of Clinical Pharmacology, 44: 487-493.
4. Witkin JM, Acri JB, Wong G, Gleeson S & Barrett JE (1996). Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons. Journal of Pharmacology and Experimental Therapeutics, 277: 87-96.
5. Fernandes C, File SE & Berry D (1996). Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam's sedative effects. Brain Research, 734: 236-242.
6. Hobbs WR & Rall TW (1996). Hypnotic and sedatives. In: Hardman JG & Limbird LE (Editors), Goodman & Gilman's The Pharmacological Basis of Therapeutics. Pergamon Press, New York, 361-396.
7. Zangrossi Jr H, Viana MB & Graeff FG (1999). Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. European Journal of Pharmacology, 369: 267-270.
8. De Sarro GB, Rotiroti D, Gratteri S, Sinopoli S, Juliano M & De Sarro A (1992). Tolerance to anticonvulsant effects of clobazam, diazepam, and clonazepam in genetically epilepsy prone rats. Advances in Biochemical Psychopharmacology, 47: 249-254.
9. Remy C (1994). Clobazam in the treatment of epilepsy: a review of the literature. Epilepsia, 35: S88-S91.
10. Bonacorso HG, Bittencourt ST, Wastowski AD, Wentz AP, Zanatta N & Martins MAP (1996). A convenient method for the synthesis of 2-trichloromethyl-4-p-substituted-phenyl-3H-1,5-benzodiazepines. Tetrahedron Letters, 37: 9155-9156.
11. Lister RG (1987). The use of plus-maze to measure anxiety in the mouse. Psychopharmacology, 92: 180-185
12. Tsuda M, Suzuki T, Misawa M & Nagase H (1996). Involvement of the opioid system in the anxiolytic effect of diazepam in mice. European Journal of Pharmacology, 307; 7-14.
13. Scorza MC, Reyes-Parada M, Silveira R, Viola H, Medina JH, Viana MB, Zangrossi Jr H & Graeff FG (1996). Behavioral effects of the putative anxiolytic (±)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice. Pharmacology, Biochemistry and Behavior, 54: 355-361.
14. Hogg S (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology. Biochemistry and Behavior, 54: 21-30.
15. Faria MS, Muscará MN, Moreno Júnior H, Teixeira SA, Dias HB, De Oliveira B, Graeff FG & De Nucci G (1997). Acute inhibition of nitric oxide synthesis nduces anxiolysis in the plus-maze test. European Journal of Pharmacology, 323: 37-43.
16. Cruz AP, Frei F & Graeff FG (1994). Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 49: 171-176.
17. Rodgers RJ, Johnson NJT, Carr J & Hodgson TP (1997). Resistance of experimentally-induced changes in murine plus-maze behaviour to altered retest conditions. Behavioural Brain Research, 86: 71-77.